{"content":"<li class=\"n-box-item date-title\" data-end=\"1504929599\" data-start=\"1504843200\" data-txt=\"Monday, December 23, 2019\">Friday, September  8, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3294525\" data-ts=\"1504912357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URI\" target=\"_blank\">URI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294525-united-rentals-prices-1_5b-in-senior-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Rentals prices $1.5B in senior debt</a></h4><ul>   <li>United Rentals (<a href=\"http://seekingalpha.com/symbol/URI\" target=\"_blank\">URI</a> <font color='green'>+2.9%</font>) has <a href=\"https://seekingalpha.com/pr/16935890-united-rentals-announces-pricing-offering-750-million-senior-notes-due-2025-750-million\" target=\"_blank\">priced a notes offering</a> by its subsidiary United Rentals North America.</li>    <li>The company priced $750M in 4.625% senior notes due 2025, and $750M in 4.875% senior notes due 2028.</li>    <li>The 2028 notes will be issued at 100.25% of principal for a yield of 4.844%.</li>    <li>Proceeds of about $1.48B will go toward part of the $1.3B acquisition of Neff.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294525\" data-linked=\"United Rentals prices $1.5B in senior debt\" data-tweet=\"$URI - United Rentals prices $1.5B in senior debt https://seekingalpha.com/news/3294525-united-rentals-prices-1_5b-in-senior-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3294525-united-rentals-prices-1_5b-in-senior-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294524\" data-ts=\"1504912111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCI\" target=\"_blank\">GCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294524-gannett-executing-job-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gannett executing more job cuts</a></h4><ul>   <li>Gannett (<a href=\"http://seekingalpha.com/symbol/GCI\" target=\"_blank\">GCI</a> <font color='red'>-2.2%</font>) is <a href=\"https://www.bizjournals.com/phoenix/news/2017/09/08/more-newspaper-job-cuts-at-gannett.html\" target=\"_blank\">executing more job cuts</a> at its newspapers, though the round this time appears to be lighter.</li>    <li>The company had 17,100 employees at the end of 2016.</li>    <li>While it hasn't detailed the nature of the cuts, a spokesperson says \"there are less than 1% of staff affected across Gannett.\"</li>    <li><a href='https://seekingalpha.com/symbol/GCI' title='Gannett Co., Inc.'>GCI</a> is <font color='red'>down 13.8%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294524\" data-linked=\"Gannett executing more job cuts\" data-tweet=\"$GCI - Gannett executing more job cuts https://seekingalpha.com/news/3294524-gannett-executing-job-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3294524-gannett-executing-job-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294522\" data-ts=\"1504911045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLS\" target=\"_blank\">SPLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294522-movers-on-s-and-p-changes-cashplus-3_9-arrplus-2_7-cpeplus-3_5-wsrplus-3_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Movers on S&amp;P changes: CASH +3.9%, ARR +2.7%, CPE +3.5%, WSR +3.6%</a></h4><ul>   <li>A set of cascading <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/580952_spls5cadencewoofbrinkwebrebal64.pdf?force_download=true\" target=\"_blank\">index changes from S&amp;P</a> due to acquisitions has some of the stocks on the move after hours.</li>    <li>Cadence Design Systems (<a href=\"http://seekingalpha.com/symbol/CDNS\" target=\"_blank\">CDNS</a> <font color='red'>-0.5%</font>) is moving to the S&amp;P 500, replacing Staples (NASDAQ:<a href='https://seekingalpha.com/symbol/SPLS' title='Staples, Inc.'>SPLS</a>), set to be acquired by Sycamore Partners. Meanwhile, ILG (<a href=\"http://seekingalpha.com/symbol/ILG\" target=\"_blank\">ILG</a> <font color='green'>+1.5%</font>) is moving to the MidCap 400 to replace Cadence, and Meta Financial Group (<a href=\"http://seekingalpha.com/symbol/CASH\" target=\"_blank\">CASH</a> <font color='green'>+3.3%</font>) jumps to the SmallCap 600 to replace ILG. <a href='https://seekingalpha.com/symbol/CASH' title='Meta Financial Group, Inc.'>CASH</a> is <font color='green'>up another 3.9%</font> after hours.</li>    <li>In changes tied to VCA's (NASDAQ:<a href='https://seekingalpha.com/symbol/WOOF' title='VCA Antech, Inc.'>WOOF</a>) acquisition by Mars Inc., Brink's (NYSE:<a href='https://seekingalpha.com/symbol/BCO' title='The Brink&#39;s Company'>BCO</a>) will move to the MidCap 400 to replace VCA, and Armour Residential REIT (<a href='https://seekingalpha.com/symbol/ARR' title='ARMOUR Residential REIT, Inc.'>ARR</a> <font color='green'>+0.5%</font>) heads to the SmallCap 600 to replace Brink's. <a href='https://seekingalpha.com/symbol/ARR' title='ARMOUR Residential REIT, Inc.'>ARR</a> is <font color='green'>up 2.7%</font> after hours, while Brink's is <font color='green'>up 0.4%</font>.</li>    <li>Callon Petroleum (<a href=\"http://seekingalpha.com/symbol/CPE\" target=\"_blank\">CPE</a> <font color='red'>-6.3%</font>) heads to the MidCap 400 to replace WebMD (NASDAQ:<a href='https://seekingalpha.com/symbol/WBMD' title='WebMD Health Corp'>WBMD</a>), set to be acquired by KKR. <a href='https://seekingalpha.com/symbol/CPE' title='Callon Petroleum Co.'>CPE</a> is <font color='green'>up 3.5%</font> after hours.</li>    <li>And Whitestone REIT (<a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a> <font color='green'>+1.3%</font>) is joining the SmallCap 600 to replace CDI (NYSE:<a href='https://seekingalpha.com/symbol/CDI' title='CDI Corporation'>CDI</a>), set to be acquired by AE Industrial Partners. <a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a> is <font color='green'>up 3.6%</font> after hours.</li>    <li>The Whitestone move is effective prior to Wednesday's open; the others are all effective before the open on Monday, Sept. 18.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294522\" data-linked=\"Movers on S&amp;P changes: CASH +3.9%, ARR +2.7%, CPE +3.5%, WSR +3.6%\" data-tweet=\"$SPLS $SPLS $CASH - Movers on S&amp;P changes: CASH +3.9%, ARR +2.7%, CPE +3.5%, WSR +3.6% https://seekingalpha.com/news/3294522-movers-on-s-and-p-changes-cashplus-3_9-arrplus-2_7-cpeplus-3_5-wsrplus-3_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3294522-movers-on-s-and-p-changes-cashplus-3_9-arrplus-2_7-cpeplus-3_5-wsrplus-3_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294519\" data-ts=\"1504908993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OHGI\" target=\"_blank\">OHGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294519-founder-rejoins-one-horizon-group-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Founder rejoins One Horizon Group as CEO</a></h4><ul>   <li>One Horizon Group (<a href=\"http://seekingalpha.com/symbol/OHGI\" target=\"_blank\">OHGI</a> <font color='green'>+5.6%</font>) says founder Mark White has <a href=\"https://seekingalpha.com/pr/16935899-one-horizon-group-founder-mark-white-rejoins-company-chief-executive-officer-lead-new-online\" target=\"_blank\">rejoined the company</a> as its CEO, president and a member of the board.</li>    <li>He'll help the company pursue a new focus after it disposed of loss-making units. It's now aiming at growth opportunities for online and software-as-a-service businesses in the security, education and gaming markets.</li>    <li>Edwin Lun is also joining the company as a Hong Kong-based chief operating officer, and will oversee the company's business in China and Hong Kong.</li>    <li>&ldquo;I am pleased to rejoin One Horizon and lead our strategy to focus on acquisitions of attractive and profitable online technology businesses,\" White says. \"There are huge opportunities to acquire businesses based in Southeast Asia with global growth opportunities.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294519\" data-linked=\"Founder rejoins One Horizon Group as CEO\" data-tweet=\"$OHGI - Founder rejoins One Horizon Group as CEO https://seekingalpha.com/news/3294519-founder-rejoins-one-horizon-group-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3294519-founder-rejoins-one-horizon-group-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294518\" data-ts=\"1504908070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294518-nfl-game-gives-nbc-ratings-win-declines-from-prior-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NFL game gives NBC ratings win, but declines from prior year</a></h4><ul>   <li>NBC (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='red'>-1%</font>) took an easy win in Thursday night's broadcast ratings, thanks to the <a href=\"http://www.hollywoodreporter.com/live-feed/2017-nfl-kickoff-ratings-1036729\" target=\"_blank\">return of NFL football</a>, but the kickoff game kept up last year's trend of shedding ratings from the previous year.</li>    <li>The Kansas City Chiefs' defeat of the New England Patriots drew 22.2M viewers in total audience delivery according to NBC, down from last year's 25.4M.</li>    <li>In ratings terms, last night's game earned an overnight 14.6 rating in households. The comparable game last year drew a 16.5 rating, and the game the year before pulled a 17.7.</li>    <li>For the night, NBC had a 6.7 rating in the 18-49 demographic, ahead of CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='red'>-1.8%</font>) at 1.1 with comedy repeats, <i>Big Brother</i> and <i>Zoo.</i> Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>) drew a 0.7 rating and ABC (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>) a 0.6.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294518\" data-linked=\"NFL game gives NBC ratings win, but declines from prior year\" data-tweet=\"$FOX $FOX $FOXA - NFL game gives NBC ratings win, but declines from prior year https://seekingalpha.com/news/3294518-nfl-game-gives-nbc-ratings-win-declines-from-prior-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3294518-nfl-game-gives-nbc-ratings-win-declines-from-prior-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>72&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294516\" data-ts=\"1504906705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294516-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='green'>+5.1%</font>. <a href='https://seekingalpha.com/symbol/IIN' title='IntriCon Corporation'>IIN</a> <font color='green'>+5.0%</font>. <a href='https://seekingalpha.com/symbol/ONS-OLD' title='Oncobiologics'>ONS-OLD</a> <font color='green'>+4.0%</font>. <a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology'>KURA</a> <font color='green'>+3.0%</font>. <a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a> <font color='green'>+2.5%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/RCII' title='Rent-A-Center Inc.'>RCII</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations'>HIIQ</a> <font color='red'>-2.0%</font>. <a href='https://seekingalpha.com/symbol/VST' title='Vistra Energy Corp.'>VST</a> <font color='red'>-2.0%</font>. <a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='red'>-1.8%</font>. <a href='https://seekingalpha.com/symbol/AFSI' title='AmTrust Financial Services, Inc.'>AFSI</a> <font color='red'>-1.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294516\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$GES $IIN $ONS-OLD - After Hours Gainers / Losers https://seekingalpha.com/news/3294516-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3294516-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294513\" data-ts=\"1504906216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEM\" target=\"_blank\">KEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294513-kemetplus-1_7-after-pricing-secondary-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KEMET +1.7% after pricing secondary share offering</a></h4><ul>   <li>KEMET (NYSE:<a href='https://seekingalpha.com/symbol/KEM' title='KEMET Corp.'>KEM</a>) has <a href=\"https://seekingalpha.com/pr/16935842-kemet-corporation-announces-pricing-secondary-offering-selling-securityholder\" target=\"_blank\">priced its secondary offering</a> of 8,416,814 shares.</li>    <li>Shares had <font color='red'>fallen 5.1%</font> yesterday after <a href=\"https://seekingalpha.com/news/3294119-kemet-minus-7-percent-news-8_4m-share-secondary-offering\" target=\"_blank\">news of the offering</a>, which is coming from a third-party holder, and <font color='red'>dropped another 6.6%</font> today to close at $20.44.</li>    <li>The underwriter is buying the exercisable warrant held by K Equity (an affiliate of Platinum Equity Capital Partners II) for $181,550,593.82 -- or just under $21.57 per underlying common share.</li>    <li>Shares are <font color='green'>up 1.7%</font> after hours, quoting at $20.78.</li>    <li>The company won't receive proceeds other than the underwriter's payment.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294513\" data-linked=\"KEMET +1.7% after pricing secondary share offering\" data-tweet=\"$KEM - KEMET +1.7% after pricing secondary share offering https://seekingalpha.com/news/3294513-kemetplus-1_7-after-pricing-secondary-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3294513-kemetplus-1_7-after-pricing-secondary-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294491\" data-ts=\"1504901923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294491-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/REMX' title='VanEck Vectors Rare Earth/Strategic Metals ETF'>REMX</a> <font color='green'>+5.3%</font>. <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='green'>+5.1%</font>. <a href='https://seekingalpha.com/symbol/BRF' title='VanEck Vectors Brazil Small-Cap ETF'>BRF</a> <font color='green'>+4.9%</font>. <a href='https://seekingalpha.com/symbol/EWZ' title='iShares MSCI Brazil Capped ETF'>EWZ</a> <font color='green'>+3.2%</font>. <a href='https://seekingalpha.com/symbol/FXY' title='Guggenheim CurrencyShares Japanese Yen Trust ETF'>FXY</a> <font color='green'>+2.2%</font>.</li>     <li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='red'>-5.1%</font>. <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a> <font color='red'>-4.3%</font>. <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a> <font color='red'>-2.7%</font>. <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='red'>-2.7%</font>. <a href='https://seekingalpha.com/symbol/KBWD' title='PowerShares KBW High Dividend Yield Financial Portfolio ETF'>KBWD</a> <font color='red'>-2.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294491\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$REMX $VXX $BRF - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3294491-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3294491-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294485\" data-ts=\"1504899748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SESN\" target=\"_blank\">SESN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294485-eleven-bio-breaks-out-shares-ahead-38\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eleven Bio breaks out, shares ahead 38%</a></h4><ul><li>Thinly traded nano cap Eleven Biotherapeutics (EBIO <font color='green'>+38.1%</font>) breaks out on a 13x surge in volume. Shares had rallied 33% before today's action but have a long way to go before returning to the high of $6 touched about a year ago.</li><li>No particular news accounts for the action, although price spikes in tiny biotechs frequently presage equity offerings. At the end of Q2, the company had $15.8M in quick assets, enough for only three quarters' operations at its current cash consumption rate.</li><li>It has two products in its pipeline: <a href=\"http://www.elevenbio.com/pipeline/vicinium.html\" target=\"_blank\">Vicinium </a>(VB4-845), a recombinant fusion protein in Phase 3 development for non-muscle invasive bladder cancer, and <a href=\"http://www.elevenbio.com/pipeline/proxinium.html\" target=\"_blank\">Proxinium </a>(VB4-847), a recombinant fusion protein in Phase 1/2 development for squamous cell carcinoma of the head and neck. Top-line three-month data from the Phase 3 should be available in mid-2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294485\" data-linked=\"Eleven Bio breaks out, shares ahead 38%\" data-tweet=\"$SESN - Eleven Bio breaks out, shares ahead 38% https://seekingalpha.com/news/3294485-eleven-bio-breaks-out-shares-ahead-38?source=tweet\" data-url=\"https://seekingalpha.com/news/3294485-eleven-bio-breaks-out-shares-ahead-38\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294484\" data-ts=\"1504899052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MHLD\" target=\"_blank\">MHLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294484-insurers-surge-weekend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insurers surge into the weekend</a></h4><ul><li>Do the folks buying and selling in the market know something the weather forecasters haven't yet figured out, or have the insurers already seen more than enough selling to price in any Harvey and Irma damage?</li><li>Headed into the close of trade for the week, the PowerShares KBW Property &amp; Casualty Insurance Portfolio (<a href='https://seekingalpha.com/symbol/KBWP' title='Invesco KBW Property & Casualty Insurance Portfolio ETF'>KBWP</a> <font color='green'>+4%</font>) is set for <a href=\"http://www.marketwatch.com/story/popular-insurance-fund-on-track-for-best-daily-gain-in-6-years-as-hurricane-irma-looms-2017-09-08\" target=\"_blank\">its largest gain in more than</a> six years.</li><li>Among the holdings: Maiden Holdings (<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='green'>+6.5%</font>), XL Group (<a href='https://seekingalpha.com/symbol/XL' title='XL Group plc'>XL</a> <font color='green'>+6%</font>), Travelers (<a href='https://seekingalpha.com/symbol/TRV' title='The Travelers Companies, Inc.'>TRV</a> <font color='green'>+4%</font>). Also being bought: Allstate (<a href='https://seekingalpha.com/symbol/ALL' title='Allstate Corporation'>ALL</a> <font color='green'>+3.5%</font>), Chubb (<a href='https://seekingalpha.com/symbol/CB' title='Chubb Ltd'>CB</a> <font color='green'>+4.6%</font>), Universal Insurance (<a href='https://seekingalpha.com/symbol/UVE' title='Universal Insurance Holdings, Inc'>UVE</a> <font color='green'>+8.8%</font>), Progressive (<a href='https://seekingalpha.com/symbol/PGR' title='Progressive Corporation'>PGR</a> <font color='green'>+3.7%</font>), Alleghany (<a href='https://seekingalpha.com/symbol/Y' title='Alleghany Corporation'>Y</a> <font color='green'>+3.8%</font>), Kinsale Capital (<a href='https://seekingalpha.com/symbol/KNSL' title='Kinsale Capital Group, Inc.'>KNSL</a> <font color='green'>+5.8%</font>), Everest Re (<a href='https://seekingalpha.com/symbol/RE' title='Everest Re Group Ltd.'>RE</a> <font color='green'>+5.6%</font>), RenaissanceRe (<a href='https://seekingalpha.com/symbol/RNR' title='RenaissanceRe Holdings Ltd.'>RNR</a> <font color='green'>+4.4%</font>), Aspen (<a href='https://seekingalpha.com/symbol/AHL' title='Aspen Insurance Holdings Limited'>AHL</a> <font color='green'>+4.1%</font>), AXIS Capital (<a href='https://seekingalpha.com/symbol/AXS' title='Axis Capital Holdings Limited'>AXS</a> <font color='green'>+4.7%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3294484\" data-linked=\"Insurers surge into the weekend\" data-tweet=\"$MHLD $KBWP $MHLD - Insurers surge into the weekend https://seekingalpha.com/news/3294484-insurers-surge-weekend?source=tweet\" data-url=\"https://seekingalpha.com/news/3294484-insurers-surge-weekend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294483\" data-ts=\"1504898948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294483-reuters-apple-warns-western-digital-away-from-toshiba-control\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Apple warns Western Digital away from Toshiba control</a></h4><ul><li>        <a href=\"http://www.reuters.com/article/us-toshiba-accounting-apple/apple-moves-to-ward-western-digital-off-control-of-toshiba-chips-sources-idUSKCN1BJ0QC?il=0\" target=\"_blank\">Reuters</a> reports that Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) has warned Western Digital (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) from trying to take control of Toshiba&rsquo;s (<a href='https://seekingalpha.com/symbol/TOSBF' title='Toshiba Corp.'>OTCPK:TOSBF</a>, <a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a>) chip unit.</li><li>                  Sources say Apple threatened to stop buying Western Digital&rsquo;s products if the company tried to use the ongoing bidding process as a way to take over the unit.    </li><li>               If Western Digital remains a minority investor in its consortium, Apple will offer $460M to help finance the bid.&nbsp;</li><li>               Apple is a top customer of Toshiba for NAND flash memory chips that go into the iPhones.&nbsp;</li><li>               Apple has also offered up financing to the Foxconn-backed consortium bidding against the Western Digital consortium.&nbsp;</li><li>Western Digital shares are&nbsp;<font color='red'>down 2.07</font>%. &nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294329-wdc-seeks-apple-funding-toshiba-bid\" target=\"_blank\">WDC seeks Apple funding for Toshiba bid</a> (Sept. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3294483\" data-linked=\"Reuters: Apple warns Western Digital away from Toshiba control\" data-tweet=\"$AAPL $AAPL $WDC - Reuters: Apple warns Western Digital away from Toshiba control https://seekingalpha.com/news/3294483-reuters-apple-warns-western-digital-away-from-toshiba-control?source=tweet\" data-url=\"https://seekingalpha.com/news/3294483-reuters-apple-warns-western-digital-away-from-toshiba-control\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>107&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294479\" data-ts=\"1504897209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294479-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MRIN' title='Marin Software'>MRIN</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/JMU' title='JMU Limited'>JMU</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SYNC' title='Synacor'>SYNC</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/AKTS' title='Akoustis Technologies, Inc.'>AKTS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AYX' title='Alteryx'>AYX</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294479\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$MRIN $VERI $OKTA - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3294479-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3294479-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294475\" data-ts=\"1504896160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTRS\" target=\"_blank\">NTRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294475-ubs-swaps-out-bny-mellon-for-northern-trust\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS swaps out BNY Mellon for Northern Trust</a></h4><ul><li>Northern Trust (<a href='https://seekingalpha.com/symbol/NTRS' title='Northern Trust Corporation'>NTRS</a> <font color='green'>+2.2%</font>) management is motivated to show value creation, says analyst Brennan Hawken, as he boosts his 2018 EPS estimate thanks to slower expense growth and net interest margin expansion, and upgrades the stock to Buy.</li><li>Alongside, he downgrades BNY Mellon (<a href='https://seekingalpha.com/symbol/BK' title='The Bank of New York Mellon Corporation'>BK</a> <font color='green'>+0.8%</font>) from Buy to Neutral as expense cuts are mostly in the rearview mirror at this point, meaning the stock is closer to fair value.</li><li>For the year, BK is&nbsp;<font color='green'>higher by 7%&nbsp;</font>and NTRS is roughly flat.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3294475\" data-linked=\"UBS swaps out BNY Mellon for Northern Trust\" data-tweet=\"$NTRS $NTRS $BK - UBS swaps out BNY Mellon for Northern Trust https://seekingalpha.com/news/3294475-ubs-swaps-out-bny-mellon-for-northern-trust?source=tweet\" data-url=\"https://seekingalpha.com/news/3294475-ubs-swaps-out-bny-mellon-for-northern-trust\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294472\" data-ts=\"1504895366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEYW\" target=\"_blank\">KEYW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294472-keyw-holding-announces-18m-army-task-order\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KEYW Holding announces $18M Army task order</a></h4><ul><li>        KEYW Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/KEYW' title='KEYW Holding'>KEYW</a>) shares&nbsp;<font color='green'>up 1.66%</font>&nbsp;after announcing an $18M task order with the U.S. Army Communications-Electronics Command Software Engineering Center.</li><li>               The task order relates to providing business systems software engineering and services. &nbsp;&nbsp;</li><li>           The new order marks KEYW&rsquo;s fifth award under the $7B Software and Systems Engineering Services Next Generation indefinite delivery / indefinite quantity contract.&nbsp; </li><li>           The new order marks KEYW&rsquo;s fifth award under the $7B Software and Systems Engineering Services Next Generation indefinite delivery / indefinite quantity contract.&nbsp;<br /> </li><li>                          <a href=\"http://investors.keywcorp.com/releasedetail.cfm?ReleaseID=1039607\" target=\"_blank\">Press release</a><br />&nbsp;<br />    &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3294472\" data-linked=\"KEYW Holding announces $18M Army task order\" data-tweet=\"$KEYW - KEYW Holding announces $18M Army task order https://seekingalpha.com/news/3294472-keyw-holding-announces-18m-army-task-order?source=tweet\" data-url=\"https://seekingalpha.com/news/3294472-keyw-holding-announces-18m-army-task-order\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294467\" data-ts=\"1504893717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPHT\" target=\"_blank\">OPHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294467-roche-lampalizumab-flop-weighs-on-ophthotech-down-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roche lampalizumab flop weighs on Ophthotech, down 10%</a></h4><ul><li>Perceiving a negative read-through from Roche's failed late-stage study of AMD candidate lampalizumab, investors are selling Ophthotech (<a href='https://seekingalpha.com/symbol/OPHT' title='Ophthotech Corporation'>OPHT</a> <font color='red'>-9.7%</font>), down on 75% higher volume.</li><li>Ophthotech was pummeled in late 2016 after failing with AMD candidate Fovista. Its other AMD candidate is anti-VEGF drug <a href=\"http://www.ophthotech.com/product-candidates/arc1905/\" target=\"_blank\">Zimura </a>which the company plans to assess in a Phase 2/3 study for the treatment of geographic atrophy, the same indication that sank lampalizumab.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294466-roches-lampalizumab-flunks-late-stage-eye-disease-study-shares-2-percent\" target=\"_blank\">Roche's lampalizumab flunks late-stage eye disease study; shares off 2%</a> (Sept. 8)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3229933-ophthotechs-fovista-flunks-two-late-stage-studies-wet-amd-shares-crater-81-percent-premarket\" target=\"_blank\">Ophthotech's Fovista flunks two late-stage studies in wet AMD; shares crater 81% premarket</a> (Dec. 12, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3294467\" data-linked=\"Roche lampalizumab flop weighs on Ophthotech, down 10%\" data-tweet=\"$OPHT $ISEE - Roche lampalizumab flop weighs on Ophthotech, down 10% https://seekingalpha.com/news/3294467-roche-lampalizumab-flop-weighs-on-ophthotech-down-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3294467-roche-lampalizumab-flop-weighs-on-ophthotech-down-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294468\" data-ts=\"1504893674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294468-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ERN' title='Erin Energy Corp.'>ERN</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/HEP' title='Holly Energy Partners, L.P.'>HEP</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GURE' title='GULF RESOURCES INC'>GURE</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/HBM' title='Hudbay Minerals Inc Ordinary Sh'>HBM</a> <font color='red'>-12%</font>. SGY <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/FTK' title='Flotek Industries, Inc.'>FTK</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294468\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$ERN $HEP $GURE - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3294468-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3294468-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294466\" data-ts=\"1504893000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHHBY\" target=\"_blank\">RHHBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294466-roches-lampalizumab-flunks-late-stage-eye-disease-study-shares-off-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roche&#39;s lampalizumab flunks late-stage eye disease study; shares off 2%</a></h4><ul><li>Roche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color='red'>-1.8%</font>) is under pressure after it <a href=\"http://www.roche.com/media/store/releases/med-cor-2017-09-08b.htm\" target=\"_blank\">announced </a>that its first Phase 3 clinical trial, Spectri, assessing lampalizumab for the treatment of geographic atrophy &#40;GA&#41; due to age-related macular degeneration failed to beat sham treatment (placebo). Further dosing will be stopped until the results from the second study, Chroma, are evaluated.</li><li>The primary endpoint of both trials is the difference in mean change in GA lesion area compared to sham.</li><li>The negative outcome is a setback for Roche, which is counting on the monoclonal antibody to be one of its growth drivers.</li><li>Previously: <a href=\"https://seekingalpha.com/news/1981825-roche-initiates-ga-drug-phase-3-trial\" target=\"_blank\">Roche initiates GA drug Phase 3 trial</a> (Sept. 15, 2014)</li></ul><div class=\"tiny-share-widget\" data-id=\"3294466\" data-linked=\"Roche&#39;s lampalizumab flunks late-stage eye disease study; shares off 2%\" data-tweet=\"$RHHBY - Roche&#39;s lampalizumab flunks late-stage eye disease study; shares off 2% https://seekingalpha.com/news/3294466-roches-lampalizumab-flunks-late-stage-eye-disease-study-shares-off-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3294466-roches-lampalizumab-flunks-late-stage-eye-disease-study-shares-off-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294465\" data-ts=\"1504892894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEAS\" target=\"_blank\">SEAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294465-tough-week-for-seaworld-entertainment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tough week for SeaWorld Entertainment</a></h4><ul><li>SeaWorld Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/SEAS' title='SeaWorld Entertainment Inc.'>SEAS</a>) is&nbsp;<font color='red'>2.88% lower&nbsp;</font>with Hurricane Irma expected to keep the company's Orlando park <a href=\"http://www.orlandosentinel.com/weather/hurricane/os-hurricane-irma-seaworld-closing-legoland-20170908-story.html\" target=\"_blank\">closed</a> for several days.</li><li>Shares are down 13% for the week, falling progressively as the extended track for Irma continued to narrow around the Orlando region. A soft traffic from Cedar Fair earlier this week was also a factor.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294052-cedar-fair-updates-results\" target=\"_blank\">Cedar Fair updates on results</a> (Sept. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3294465\" data-linked=\"Tough week for SeaWorld Entertainment\" data-tweet=\"$SEAS - Tough week for SeaWorld Entertainment https://seekingalpha.com/news/3294465-tough-week-for-seaworld-entertainment?source=tweet\" data-url=\"https://seekingalpha.com/news/3294465-tough-week-for-seaworld-entertainment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294464\" data-ts=\"1504891988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294464-lululemon-perks-up-amid-m-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon perks up amid M&amp;A chatter</a></h4><ul><li>Shares of Lululemon (<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+1.6%</font>) are jumping around amid a fresh round of M&amp;A rumors.</li><li>Volume on LULU is above normal activity. The athletic apparel stock reached $63 for the first time since March.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294464\" data-linked=\"Lululemon perks up amid M&amp;A chatter\" data-tweet=\"$LULU - Lululemon perks up amid M&amp;A chatter https://seekingalpha.com/news/3294464-lululemon-perks-up-amid-m-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3294464-lululemon-perks-up-amid-m-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294461\" data-ts=\"1504891885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRY\" target=\"_blank\">ARRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294461-array-bios-binimetinib-and-encorafenib-show-encouraging-treatment-effect-in-initial-phase-of\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Array Bio&#39;s binimetinib and encorafenib show encouraging treatment effect in initial phase of late-stage study in treatment-resistant colorectal cancer; shares ahead 17%</a></h4><ul><li>Array BioPharma (<a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='green'>+16.7%</font>) is up on double normal volume on the heels of its <a href=\"https://seekingalpha.com/pr/16935700-phase-3-beacon-crc-safety-lead-results-braf-mutant-colorectal-cancer-presented-european\" target=\"_blank\">announcement </a>of positive data from a Phase 3 clinical trial, BEACON CRC, assessing the combination of binimetinib, encorafenib and Eli Lilly's Erbitux (cetuximab) in patients with metastatic BRAF-positive colorectal cancer &#40;CRC&#41; whose disease has progressed after one or two prior lines of therapy, a population of patients with a very poor prognosis. The data were presented today as ESMO in Madrid.</li><li>In 30 patients treated in the safety lead-in phase of the trial, the confirmed overall response rate &#40;ORR&#41;&nbsp;was 41%, including one complete responder. The observed ORR was 59% in the 17 BRAF-positive patients with only one prior therapy. Almost all (n=27/28) of the patients with both a BRAF mutation and post-baseline assessment showed tumor regression.</li><li>The triplet therapy was generally well-tolerated. The most common grade 3 (serious) or grade 4 (life threatening) adverse events were nausea (10%), vomiting (10%), increased blood creatinine kinase (biomarker for muscle inflammation/damage) and urinary tract infection (10%).</li><li>In July, Array submitted two marketing applications to the FDA for the combination use of binimetinib and encorafenib in patients with BRAF-positive advanced/unresectable/metastatic melanoma. The marketing applications in Europe, filed by commercialization partner Pierre Fabre, are currently under review.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294461\" data-linked=\"Array Bio&#39;s binimetinib and encorafenib show encouraging treatment effect in initial phase of late-stage study in treatment-resistant colorectal cancer; shares ahead 17%\" data-tweet=\"$ARRY - Array Bio&#39;s binimetinib and encorafenib show encouraging treatment effect in initial phase of late-stage study in treatment-resistant colorectal cancer; shares ahead 17% https://seekingalpha.com/news/3294461-array-bios-binimetinib-and-encorafenib-show-encouraging-treatment-effect-in-initial-phase-of?source=tweet\" data-url=\"https://seekingalpha.com/news/3294461-array-bios-binimetinib-and-encorafenib-show-encouraging-treatment-effect-in-initial-phase-of\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294462\" data-ts=\"1504890920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASY\" target=\"_blank\">CASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294462-hedgeye-negative-on-caseys-general-stores\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hedgeye negative on Casey&#39;s General Stores</a></h4><ul><li>Casey's General Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/CASY' title='Casey&#39;s General Stores, Inc.'>CASY</a>) falls on the list of short ideas from <a href=\"https://app.hedgeye.com/\" target=\"_blank\">Hedgeye</a>.</li><li>The firm isn't impressed with Casey's plan add stores into a trend of slowing same-store sales and pressured margins.</li><li>Casey's is&nbsp;<font color='red'>down 1.40%</font>&nbsp;on the day and is off 10% YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294462\" data-linked=\"Hedgeye negative on Casey&#39;s General Stores\" data-tweet=\"$CASY - Hedgeye negative on Casey&#39;s General Stores https://seekingalpha.com/news/3294462-hedgeye-negative-on-caseys-general-stores?source=tweet\" data-url=\"https://seekingalpha.com/news/3294462-hedgeye-negative-on-caseys-general-stores\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294459\" data-ts=\"1504890350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294459-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FNHC' title='FedNat Holding Company'>FNHC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/UVE' title='Universal Insurance Holdings, Inc'>UVE</a> <font color='green'>+9%</font>.<a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ZAIS' title='ZAIS Group Holdings'>ZAIS</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CIA' title='Citizens, Inc.'>CIA</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/EFX' title='Equifax Inc.'>EFX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/BCBP' title='BCB Bancorp, Inc. &#40;NJ&#41;'>BCBP</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/BCRH' title='Blue Capital Reinsurance Holdings Ltd.'>BCRH</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ELS' title='Equity Lifestyle Properties, Inc.'>ELS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294459\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$FNHC $UVE $SGLB - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3294459-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3294459-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294454\" data-ts=\"1504889374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294454-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology'>KURA</a> <font color='green'>+86%</font>. <a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a> <font color='green'>+34%</font>. EBIO <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/ZUMZ' title='Zumiez Inc.'>ZUMZ</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/ERN' title='Erin Energy Corp.'>ERN</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/VTL' title='Vital Therapies, Inc.'>VTL</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/SHOS' title='Sears Hometown and Outlet Stores, Inc.'>SHOS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/ADAP' title='Adaptimmune Therapeutics plc'>ADAP</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='green'>+13%</font>.</li><li><b>Losers:&nbsp;</b><a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/CHKE' title='Cherokee Inc.'>CHKE</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/EFX' title='Equifax Inc.'>EFX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/HBM' title='Hudbay Minerals Inc Ordinary Sh'>HBM</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/BCBP' title='BCB Bancorp, Inc. &#40;NJ&#41;'>BCBP</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/UTHR' title='United Therapeutics Corporation'>UTHR</a> <font color='red'>-10%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a>&nbsp;<font color='red'>-10%</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3294454\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$KURA $NLNK $SESN - Midday Gainers / Losers https://seekingalpha.com/news/3294454-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3294454-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294453\" data-ts=\"1504889110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRY\" target=\"_blank\">ARRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294453-trading-halted-array-biopharma-pending-news-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading halted Array BioPharma pending news; shares up 5%</a></h4><ul><li>Nasdaq has suspended trading in Array BioPharma (<a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='green'>+5.1%</font>) pending the release of news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294453\" data-linked=\"Trading halted Array BioPharma pending news; shares up 5%\" data-tweet=\"$ARRY - Trading halted Array BioPharma pending news; shares up 5% https://seekingalpha.com/news/3294453-trading-halted-array-biopharma-pending-news-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3294453-trading-halted-array-biopharma-pending-news-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294448\" data-ts=\"1504887431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMT\" target=\"_blank\">WMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294448-retailers-head-lower-target-cuts-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retailers head lower as Target cuts prices</a></h4><ul><li>Target is<font color='red'> lower by more than 3%</font>&nbsp;after announcing price cuts on thousands of items.</li><li>Down in concert: Wal-Mart (<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a> <font color='red'>-2%</font>), Costco (<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a> <font color='red'>-2%</font>), Dollar General (<a href='https://seekingalpha.com/symbol/DG' title='Dollar General Corporation'>DG</a> <font color='red'>-1.7%</font>), Big Lots (<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a> <font color='red'>-0.9%</font>)</li><li><a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>&nbsp;<font color='red'>-1.05%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLP' title='Consumer Staples Select Sector SPDR ETF'>XLP</a>, <a href='https://seekingalpha.com/symbol/VDC' title='Vanguard Consumer Staples ETF'>VDC</a>, <a href='https://seekingalpha.com/symbol/RHS' title='Invesco S&P Equal Weight Consumer Staples ETF'>RHS</a>, <a href='https://seekingalpha.com/symbol/PBJ' title='Invesco Dynamic Food & Beverage Portfolio ETF'>PBJ</a>, <a href='https://seekingalpha.com/symbol/FXG' title='First Trust Consumer Staples AlphaDEX ETF'>FXG</a>, <a href='https://seekingalpha.com/symbol/FSTA' title='Fidelity MSCI Consumer Staples Index ETF'>FSTA</a>, <a href='https://seekingalpha.com/symbol/IYK' title='iShares U.S. Consumer Goods ETF'>IYK</a>, <a href='https://seekingalpha.com/symbol/UGE' title='ProShares Ultra Consumer Goods ETF'>UGE</a>, <a href='https://seekingalpha.com/symbol/SZK' title='ProShares UltraShort Consumer Goods ETF'>SZK</a>, <a href='https://seekingalpha.com/symbol/CNSF' title='iShares Edge MSCI Multifactor Consumer Staples ETF'>CNSF</a>, <a href='https://seekingalpha.com/symbol/JHMS' title='John Hancock Multifactor Consumer Staples ETF'>JHMS</a>, <a href='https://seekingalpha.com/symbol/FTXG' title='First Trust Nasdaq Food & Beverage ETF'>FTXG</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3294447-target-nearly-3-percent-price-cuts\" target=\"_blank\">Target down more than 3% on price cuts</a> (Sept. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3294448\" data-linked=\"Retailers head lower as Target cuts prices\" data-tweet=\"$WMT $WMT $COST - Retailers head lower as Target cuts prices https://seekingalpha.com/news/3294448-retailers-head-lower-target-cuts-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3294448-retailers-head-lower-target-cuts-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294447\" data-ts=\"1504887199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294447-target-down-3-on-price-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Target down more than 3% on price cuts</a></h4><ul><li>\"We&rsquo;ve lowered our prices on thousands of items,\" says Target (NYSE:<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a>) in <a href=\"https://corporate.target.com/article/2017/09/save-big-during-target-run\" target=\"_blank\">a blog post</a>.</li><li>The stock has dropped to session lows,&nbsp;<font color='red'>off 3.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294447\" data-linked=\"Target down more than 3% on price cuts\" data-tweet=\"$TGT - Target down more than 3% on price cuts https://seekingalpha.com/news/3294447-target-down-3-on-price-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3294447-target-down-3-on-price-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294444\" data-ts=\"1504886546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294444-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/OBCI' title='Ocean Bio-Chem, Inc.'>OBCI</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/REVG' title='REV Group'>REVG</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries Inc.'>OXM</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294444\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$CELH $WATT $OBCI - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3294444-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3294444-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294442\" data-ts=\"1504886285\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONS-OLD\" target=\"_blank\">ONS-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294442-oncobiologics-secures-25m-private-capital-raise-shares-ahead-74\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oncobiologics secures $25M private capital raise; shares ahead 74%</a></h4><ul><li>Thinly traded nano cap Oncobiologics (<a href='https://seekingalpha.com/symbol/ONS-OLD' title='Oncobiologics'>ONS-OLD</a> <font color='green'>+74.4%</font>) jumps on a 26x surge in volume on its <a href=\"https://seekingalpha.com/pr/16935429-oncobiologics-announces-strategic-partnership-gms-tenshi-holdings-pte-limited\" target=\"_blank\">agreement</a> with GMS Tenshi Holdings Pte. Limited for the sale of $25M of its Series A Convertible Preferred Stock plus warrants to purchase up to an additional 16.75M shares at an aggregate price of ~$15M (~$0.90/share).</li><li>Net proceeds will fund the initiation of Phase 3 studies for lead candidate ONS-3010 (biosimilar of Humira), working capital and general corporate purposes.</li><li>Concurrently, the company and GMS ink a separate agreement granting GMS the rights to ONS-3010 and ONS-1045 (Avastin biosimilar) in emerging markets, exclusive of China, India and Mexico. The new deal replaces the previous contract which applied only to ONS-1045 and includes an additional $2.5M upfront payment and up to $5M in milestones.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294442\" data-linked=\"Oncobiologics secures $25M private capital raise; shares ahead 74%\" data-tweet=\"$ONS-OLD - Oncobiologics secures $25M private capital raise; shares ahead 74% https://seekingalpha.com/news/3294442-oncobiologics-secures-25m-private-capital-raise-shares-ahead-74?source=tweet\" data-url=\"https://seekingalpha.com/news/3294442-oncobiologics-secures-25m-private-capital-raise-shares-ahead-74\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294439\" data-ts=\"1504885019\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294439-bloomberg-court-sides-apple-in-qualcomm-royalty-dispute-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Court sides with Apple in Qualcomm royalty dispute (update)</a></h4><ul><li>Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>)&nbsp;<font color='red'>drops 2.2%</font>&nbsp;as Bloomberg says a federal judge in San Diego sided with Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) in a royalty dispute.</li><li>Qualcomm wanted to force Apple contractors to pay royalties while other legal matters were ongoing.</li><li>More information when available.</li><li>Update: <a href=\"https://www.wsj.com/articles/qualcomm-loses-bid-to-dismiss-apple-manufacturers-suit-over-royalties-1504893104\" target=\"_blank\">The Wall Street Journal </a>has the details.</li><li>A federal judge denies Qualcomm's request to dismiss the royalty lawsuit filed by Apple's manufacturers, meaning those parties can keep withholding payments for the time being.</li><li>Apple statement: &ldquo;Qualcomm must establish the fair value of its technology and defend its business practices in court.&rdquo;</li><li>Qualcomm statement:&nbsp;&ldquo;While we are disappointed by today&rsquo;s rulings, we recognize that the motions involved high procedural hurdles.&rdquo;</li><li>Qualcomm shares currently&nbsp;<font color='red'>down 1.75%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294439\" data-linked=\"Bloomberg: Court sides with Apple in Qualcomm royalty dispute (update)\" data-tweet=\"$QCOM $QCOM $AAPL - Bloomberg: Court sides with Apple in Qualcomm royalty dispute (update) https://seekingalpha.com/news/3294439-bloomberg-court-sides-apple-in-qualcomm-royalty-dispute-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3294439-bloomberg-court-sides-apple-in-qualcomm-royalty-dispute-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>145&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294435\" data-ts=\"1504884946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMDZ\" target=\"_blank\">IMDZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294435-immune-designs-cmb305-shows-treatment-effect-in-mid-stage-sts-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immune Design&#39;s CMB305 shows treatment effect in mid-stage STS study</a></h4><ul><li>Thinly traded micro cap Immune Design (<a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a> <font color='red'>-6%</font>) is down on modestly higher volume as investors appear to be \"selling on the news\" on the heels of its <a href=\"https://seekingalpha.com/pr/16935244-new-randomized-data-cmb305-checkpoint-inhibitor-study-demonstrate-greater-clinical-benefit\" target=\"_blank\">announcement </a>of positive interim results from a Phase 2 clinical trial assessing the combination of prime boost cancer vaccine candidate CMB305, combined with Roche's TECENTRIQ (atezolizumab), in patients with NY-ESO-1-positive soft tissue sarcoma &#40;STS&#41;.</li><li>The 88-subject study is comparing the combination (n=45) to atezolizumab alone (n=43). The disease control rate &#40;DCR&#41;&nbsp;(partial responders + stable disease) in the combination group was 61%, including one partial responder. The DCR in the atezolizumab-only group was 28% with no partial responders.</li><li>Median progression-free survival favored the combination cohort, 2.6 months versus 1.4 months, as did time-to-next treatment, 9.0 months versus 6.3 months. Overall survival data will be presented after all patients have at least one year of follow-up.</li><li><a href=\"http://www.immunedesign.com/pipeline/\" target=\"_blank\">CMB305&nbsp;</a>is a prime-boost vaccine against NY-ESO-1-expressing tumors designed to generate an integrated anti-NY-ESO-1 response via its specific interaction with messengers between the innate and adaptive immune systems called&nbsp;<a href=\"https://en.wikipedia.org/wiki/Dendritic_cell\" target=\"_blank\">dendritic cells</a>. The company says its approach is different from other cancer vaccines.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294435\" data-linked=\"Immune Design&#39;s CMB305 shows treatment effect in mid-stage STS study\" data-tweet=\"$IMDZ - Immune Design&#39;s CMB305 shows treatment effect in mid-stage STS study https://seekingalpha.com/news/3294435-immune-designs-cmb305-shows-treatment-effect-in-mid-stage-sts-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3294435-immune-designs-cmb305-shows-treatment-effect-in-mid-stage-sts-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294433\" data-ts=\"1504883763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVI\" target=\"_blank\">NAVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294433-navient-up-nearly-4-credit-suisse-buys-dip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navient up nearly 4% as Credit Suisse buys the dip</a></h4><ul><li>After about a&nbsp;<font color='red'>10% summer decline</font>, the stock's too cheap, says analyst Moshe Orenbuch, noting it's selling at the bottom of its recent 7x-9x earnings multiple range.</li><li>Among the catalysts for gains are strong cash flows and capital returns next year, better margins supported by better Libor spreads, and reduced regulatory risk.</li><li>He upgrades to Outperform with $16.50 price target (more than 20% upside).</li><li><a href='https://seekingalpha.com/symbol/NAVI' title='Navient Corp'>NAVI</a>&nbsp;<font color='green'>+3.8%</font>&nbsp;to $13.64</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3294433\" data-linked=\"Navient up nearly 4% as Credit Suisse buys the dip\" data-tweet=\"$NAVI - Navient up nearly 4% as Credit Suisse buys the dip https://seekingalpha.com/news/3294433-navient-up-nearly-4-credit-suisse-buys-dip?source=tweet\" data-url=\"https://seekingalpha.com/news/3294433-navient-up-nearly-4-credit-suisse-buys-dip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294429\" data-ts=\"1504883182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPTX\" target=\"_blank\">LPTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294429-european-cancer-research-group-sponsors-study-to-evaluate-combination-regimen-including-leaps\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European cancer research group sponsors study to evaluate combination regimen including Leap&#39;s DKN-01 in esophagogastric and biliary tract cancers</a></h4><ul><li>Leap Therapeutics (<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics'>LPTX</a> <font color='red'>-3.9%</font>) will collaborate with the European Organisation for Research and Treatment of Cancer &#40;EORTC&#41; on a clinical study investigating certain combination regimens that include lead product candidate DKN-01 in advanced cancers.</li><li>The EORTC-sponsored trial will assess the combination of DKN-01 and Roche's TECENTRIQ (atezolizumab), with or without the chemo agent paclitaxel, in patients with advanced esophagogastric cancers and DKN-01 + TECENTRIQ in patients with advanced biliary tract cancers. Roche will supply product. Enrollment should commence in 2018.</li><li><a href=\"http://www.leaptx.com/science/#modulate-wnt-signaling\" target=\"_blank\">DKN-01</a>&nbsp;is a humanized IgG4 monoclonal antibody that binds to&nbsp;<a href=\"https://en.wikipedia.org/wiki/DKK1\" target=\"_blank\">Dickkopf-1</a>&nbsp;(DKK1), a protein associated with a poor prognosis in a range of cancers. Specifically, it inhibits a pathway called canonical Wnt/Beta-catenin which plays a key role in embryonic development, cell proliferation and differentiation.</li><li>Investors appear unimpressed. The stock is down on 40% higher volume, albeit on turnover of only 24k shares.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274770-leap-therapeutics-explore-potential-dknminus-01-keytruda-combo-treatment-resistant\" target=\"_blank\">Leap Therapeutics to explore the potential of DKN-01/Keytruda combo in treatment -resistant esophagogastric cancers; shares ahead 5%</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3294429\" data-linked=\"European cancer research group sponsors study to evaluate combination regimen including Leap&#39;s DKN-01 in esophagogastric and biliary tract cancers\" data-tweet=\"$LPTX - European cancer research group sponsors study to evaluate combination regimen including Leap&#39;s DKN-01 in esophagogastric and biliary tract cancers https://seekingalpha.com/news/3294429-european-cancer-research-group-sponsors-study-to-evaluate-combination-regimen-including-leaps?source=tweet\" data-url=\"https://seekingalpha.com/news/3294429-european-cancer-research-group-sponsors-study-to-evaluate-combination-regimen-including-leaps\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294427\" data-ts=\"1504882861\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDR\" target=\"_blank\">CLDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294427-cloudera-acquires-ai-training-and-consultancy-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloudera acquires AI training and consultancy company</a></h4><ul><li>        Cloudera (NYSE:<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a>) <a href=\"https://techcrunch.com/2017/09/07/cloudera-acquires-ai-research-startup-fast-forward-labs/\" target=\"_blank\">acquires</a> machine learning training and consulting company Fast Forward Labs.</li><li>                  The acquisition was announced in the company&rsquo;s aftermarket Q2 earnings yesterday.    </li><li>               Terms not disclosed.&nbsp;</li><li>               Fast Forward Labs teaches enterprises how to utilize AI trends to stimulate growth, which should meld well with Cloudera&rsquo;s specialty of operating big data and machine learning projects on an open-source backbone.&nbsp;&nbsp;</li><li>        Cloudera shares are&nbsp;<font color='red'>down 2.2%</font>&nbsp;despite reporting Q2 beats.&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294255-cloudera-beats-0_08-beats-revenue\" target=\"_blank\">Cloudera beats by $0.08, beats on revenue</a> (Sept. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3294427\" data-linked=\"Cloudera acquires AI training and consultancy company\" data-tweet=\"$CLDR - Cloudera acquires AI training and consultancy company https://seekingalpha.com/news/3294427-cloudera-acquires-ai-training-and-consultancy-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3294427-cloudera-acquires-ai-training-and-consultancy-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294411\" data-ts=\"1504882855\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294411-healthcare-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology'>KURA</a> <font color='green'>+87%</font>. <a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a> <font color='green'>+39%</font>. <a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ADAP' title='Adaptimmune Therapeutics plc'>ADAP</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/UTHR' title='United Therapeutics Corporation'>UTHR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AGLE' title='Aeglea BioTherapeutics'>AGLE</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SBPH' title='Spring Bank Pharmaceuticals'>SBPH</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294411\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am\" data-tweet=\"$KURA $NLNK $VSTM - Healthcare Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3294411-healthcare-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3294411-healthcare-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294425\" data-ts=\"1504882124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294425-grocery-store-stocks-follow-kroger-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grocery store stocks follow Kroger lower</a></h4><ul>     <li>The grocery store sector is getting hit hard after Kroger (<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a> <font color='red'>-6.5%</font>) posted earnings. The grocery store operator noted that's not losing customers, but pricing competition is having an impact on the bottom line.</li>     <li>Smart &amp; Final Stores (<a href='https://seekingalpha.com/symbol/SFS' title='Smart & Final Stores'>SFS</a> <font color='red'>-7.6%</font>), Supervalu (<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color='red'>-5.2%</font>), Weis Markets (<a href='https://seekingalpha.com/symbol/WMK' title='Weis Markets Inc'>WMK</a> <font color='red'>-1.8%</font>), and Natural Grocers by Vitamin Cottage (<a href='https://seekingalpha.com/symbol/NGVC' title='Natural Grocers'>NGVC</a> <font color='red'>-3.3%</font>) are all down.</li>     <li>Food distributers SpartanNash (<a href='https://seekingalpha.com/symbol/SPTN' title='SpartanNash Company'>SPTN</a> <font color='red'>-3.9%</font>) and Chef's Warehouse (<a href='https://seekingalpha.com/symbol/CHEF' title='Chefs&#39; Warehouse'>CHEF</a> <font color='red'>-1.8%</font>) are also feeling the impact.</li>     <li>Target (NYSE:<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a>) is&nbsp;<font color='red'>down 1%</font> in early trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294363-kroger-eps-line-beats-revenue\" target=\"_blank\">Kroger EPS in-line, beats on revenue</a> (Sept. 8)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294397-kroger-falls-sharply-earnings\" target=\"_blank\">Kroger falls sharply after earnings</a> (Sept. 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294425\" data-linked=\"Grocery store stocks follow Kroger lower\" data-tweet=\"$KR $KR $SFS - Grocery store stocks follow Kroger lower https://seekingalpha.com/news/3294425-grocery-store-stocks-follow-kroger-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3294425-grocery-store-stocks-follow-kroger-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294424\" data-ts=\"1504881908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELS\" target=\"_blank\">ELS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294424-equity-lifestyleminus-4_8-downgraded-thanks-to-irma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Equity Lifestyle -4.8%; downgraded thanks to Irma</a></h4><ul><li>The kick-off of \"snowbird\" season isn't going to be a great one thanks to Irma, says Baird's Drew Babin, downgrading Equity Lifestyle (<a href='https://seekingalpha.com/symbol/ELS' title='Equity Lifestyle Properties, Inc.'>ELS</a> <font color='red'>-4.8%</font>) to Neutral.</li><li>The stock's valuation, he says, already reflects plenty of optimism for the manufactured housing/RV business.</li><li>Also with plenty of exposure to manufactured housing in Florida is Sun Communities (<a href='https://seekingalpha.com/symbol/SUI' title='Sun Communities Inc.'>SUI</a> <font color='red'>-3.5%</font>).</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3294424\" data-linked=\"Equity Lifestyle -4.8%; downgraded thanks to Irma\" data-tweet=\"$ELS $ELS $SUI - Equity Lifestyle -4.8%; downgraded thanks to Irma https://seekingalpha.com/news/3294424-equity-lifestyleminus-4_8-downgraded-thanks-to-irma?source=tweet\" data-url=\"https://seekingalpha.com/news/3294424-equity-lifestyleminus-4_8-downgraded-thanks-to-irma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294421\" data-ts=\"1504881705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPGN\" target=\"_blank\">OPGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294421-opgens-rapid-pcr-test-for-antibiotic-susceptibility-shows-agreement-high-99-standard-approach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Opgen&#39;s rapid PCR test for antibiotic susceptibility shows agreement as high as 99% with standard approach; shares ahead 4%</a></h4><ul><li>Nano cap Opgen (<a href='https://seekingalpha.com/symbol/OPGN' title='OpGen'>OPGN</a> <font color='green'>+3.7%</font>) perks up on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/16935333-opgen-data-new-rapid-gene-test-antibiotic-susceptibility-prediction-algorithms-presented-2017\" target=\"_blank\">announcement </a>of positive data from an in-house study comparing the ability of its high-throughput PCR assay to predict antibiotic susceptibility compared to standard susceptibility testing. The results were presented at the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance in Boston.</li><li>The data showed the company's Acuitas AMR Gene Panel u5.47, a Research Use Only semi-quantitative PCR test that rapidly detects antibiotic-resistant genes, and the Acuitas Lighthouse Knowledgebase, for the interpretation of results, substantially agreed with standard susceptibility testing.</li><li>Specifically, Lighthouse predicted phenotypic antibiotic resistance for 17 antibiotics on 47 resistance genes, with agreement ranging from 79 - 97% for <em>E. coli</em>; 78 - 90% for <em>K. pneumoniae</em>; 46 - 84% for <em>P. aeruginosa</em> and 76 - 99% for <em>P. mirabilis</em>.</li><li>The company does not disclose the specific turnaround time for its rapid test, but the type of PCR assay it is using can typically generate results in a few hours. Standard antibiotic susceptibility testing can take <a href=\"http://jcm.asm.org/content/43/7/3159.full\" target=\"_blank\">one - two weeks</a>, depending on the isolate, so same-day turnaround would be a significant value add.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294421\" data-linked=\"Opgen&#39;s rapid PCR test for antibiotic susceptibility shows agreement as high as 99% with standard approach; shares ahead 4%\" data-tweet=\"$OPGN - Opgen&#39;s rapid PCR test for antibiotic susceptibility shows agreement as high as 99% with standard approach; shares ahead 4% https://seekingalpha.com/news/3294421-opgens-rapid-pcr-test-for-antibiotic-susceptibility-shows-agreement-high-99-standard-approach?source=tweet\" data-url=\"https://seekingalpha.com/news/3294421-opgens-rapid-pcr-test-for-antibiotic-susceptibility-shows-agreement-high-99-standard-approach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294423\" data-ts=\"1504881511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZG\" target=\"_blank\">ZG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294423-zillow-acquires-listing-management-platform-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zillow acquires listing management platform company</a></h4><ul><li>        Zillow (NASDAQ:<a href='https://seekingalpha.com/symbol/ZG' title='Zillow Group, Inc.'>ZG</a>) has <a href=\"https://venturebeat.com/2017/09/08/zillow-acquires-new-home-feed-to-help-builders-market-their-homes-to-potential-buyers/\" target=\"_blank\">acquired</a> listing management platform and marketing company New Home Feed.&nbsp;</li><li>        Terms of the deal not disclosed.&nbsp;</li><li>        &ldquo;By incorporating New Home Feed&rsquo;s tool set into our offering, it will be easier for partners to send their listings to Zillow Group and will improve the quality and accuracy of our new construction listings. This acquisition is another step toward our ultimate goal for new construction at Zillow Group, which is to help builders market their homes to consumers with a great return on investment,&rdquo; says Zillow VP of emerging marketplaces Tony Small.&nbsp;</li><li>        Zillow shares are&nbsp;<font color='red'>down 1.62%</font>.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3294423\" data-linked=\"Zillow acquires listing management platform company\" data-tweet=\"$ZG - Zillow acquires listing management platform company https://seekingalpha.com/news/3294423-zillow-acquires-listing-management-platform-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3294423-zillow-acquires-listing-management-platform-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294419\" data-ts=\"1504880324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKZOY\" target=\"_blank\">AKZOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294419-coating-companies-dip-after-akzo-nobel-cuts-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coating companies dip after Akzo Nobel cuts guidance</a></h4><ul><li>Akzo Nobel (<a href='https://seekingalpha.com/symbol/AKZOY' title='Akzo Nobel N.V. ADR'>OTCQX:AKZOY</a> <font color='red'>-0.4%</font>) issued a profit warning and announced the departure of its CFO. Shares have recovered most of a sizable early loss.</li><li>Peers are under pressure: Axalta Coating (<a href='https://seekingalpha.com/symbol/AXTA' title='Axalta Coating Systems'>AXTA</a> <font color='red'>-1.2%</font>), RPM International (<a href='https://seekingalpha.com/symbol/RPM' title='RPM International Inc.'>RPM</a> <font color='red'>-1.2%</font>), PPG Industries (<a href='https://seekingalpha.com/symbol/PPG' title='PPG Industries, Inc.'>PPG</a> <font color='red'>-1.2%</font>), Sherwin-Williams (<a href='https://seekingalpha.com/symbol/SHW' title='The Sherwin-Williams Company'>SHW</a> <font color='red'>-0.7%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294339-akzo-abandons-profit-forecasts\" target=\"_blank\">Akzo abandons profit forecasts</a> (Sept. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3294419\" data-linked=\"Coating companies dip after Akzo Nobel cuts guidance\" data-tweet=\"$AKZOY $AKZOY $AXTA - Coating companies dip after Akzo Nobel cuts guidance https://seekingalpha.com/news/3294419-coating-companies-dip-after-akzo-nobel-cuts-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3294419-coating-companies-dip-after-akzo-nobel-cuts-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294418\" data-ts=\"1504880071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAIC\" target=\"_blank\">SAIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294418-seaport-lowers-science-applications-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seaport lowers Science Applications price target</a></h4><ul><li>        Seaport Global Securities lowers its Science Applications (NYSE:<a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a>) price target by $3 to $80 but maintains a Buy rating.</li><li>               Analyst Josh Sullivan cites a slowing fixed-priced transition but notes the record-setting bookings.&nbsp;</li><li>               Source: <a href=\"https://www.streetinsider.com/Analyst+Comments/Science+Applications+%28SAIC%29+PT+Lowered+to+%2480+at+Seaport+Global+Securities/13278003.html\" target=\"_blank\">StreetInsider</a>&nbsp;</li><li>               Science Applications shares are&nbsp;<font color='red'>down 18.2%</font>&nbsp;after yesterday&rsquo;s aftermarket Q2 report missed EPS estimates.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294270-science-applications-misses-0_10-revenue-line\" target=\"_blank\">Science Applications misses by $0.10,  revenue in-line</a> (Sept. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3294418\" data-linked=\"Seaport lowers Science Applications price target\" data-tweet=\"$SAIC - Seaport lowers Science Applications price target https://seekingalpha.com/news/3294418-seaport-lowers-science-applications-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3294418-seaport-lowers-science-applications-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294417\" data-ts=\"1504879432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294417-chipotle-slides-after-cowen-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle slides after Cowen downgrade</a></h4><ul> <li>Cowen &amp; Company <a href=\"https://www.bizjournals.com/denver/news/2017/09/08/chipotle-shares-downgraded-by-analyst-who-cites.html\" target=\"_blank\">downgrades</a> Chipotle (<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a> <font color='red'>-3.9%</font>) to Underperform from Market Perform.</li> <li>Analyst Andrew Charles warns that the restaurant chain's quality and value perceptions remain near \"trough levels\" and same-store sales pressure could persist.</li> <li>The queso menu introduction isn't seen providing enough of a sales lift, while Chipotle's focus on store operations over unit growth could reel in investor expectations.</li> <li>Cowen's price target moves to $250 from $370 to rep 18% downside potential.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294417\" data-linked=\"Chipotle slides after Cowen downgrade\" data-tweet=\"$CMG - Chipotle slides after Cowen downgrade https://seekingalpha.com/news/3294417-chipotle-slides-after-cowen-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3294417-chipotle-slides-after-cowen-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294414\" data-ts=\"1504879076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZEN\" target=\"_blank\">ZEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294414-evercore-isi-initiates-zendesk-coverage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore ISI initiates Zendesk coverage</a></h4><ul><li>        Zendesk (NYSE:<a href='https://seekingalpha.com/symbol/ZEN' title='Zendesk, Inc.'>ZEN</a>) shares&nbsp;<font color='green'>up 1.21%</font>&nbsp;after Evercore ISI initiates the customer service software company with an Outperform rating and a $34 price target, about 19% above the current trading price.</li><li>               Analyst Kirk Materne says Zendesk is one of the best positioned in its market and estimates a $13.2B total addressable market with a growth rate over 13%. The TAM could support over 30% revenue growth over the next three years.&nbsp;</li><li>               Source: The Fly</a>&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3294414\" data-linked=\"Evercore ISI initiates Zendesk coverage\" data-tweet=\"$ZEN - Evercore ISI initiates Zendesk coverage https://seekingalpha.com/news/3294414-evercore-isi-initiates-zendesk-coverage?source=tweet\" data-url=\"https://seekingalpha.com/news/3294414-evercore-isi-initiates-zendesk-coverage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294412\" data-ts=\"1504878880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/I\" target=\"_blank\">I</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294412-intelsatplus-1_5-echostarminus-1_7-on-new-ratings-jefferies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelsat +1.5%, EchoStar -1.7% on new ratings at Jefferies</a></h4><ul>   <li>Intelsat (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a>) is <font color='green'>up 1.5%</font> after a boost to Buy at Jefferies Group.</li>    <li>The firm had previously rated it Hold; it's boosting Intelsat's price target to $5 from $2.50, implying 24% upside.</li>    <li>Jefferies has also initiated coverage of EchoStar (NASDAQ:<a href='https://seekingalpha.com/symbol/SATS' title='EchoStar Corporation'>SATS</a>) at Hold; shares are <font color='red'>down 1.7%</font>. Its price target on that stock is $65, implying 16.6% upside from current pricing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294412\" data-linked=\"Intelsat +1.5%, EchoStar -1.7% on new ratings at Jefferies\" data-tweet=\"$I $I $SATS - Intelsat +1.5%, EchoStar -1.7% on new ratings at Jefferies https://seekingalpha.com/news/3294412-intelsatplus-1_5-echostarminus-1_7-on-new-ratings-jefferies?source=tweet\" data-url=\"https://seekingalpha.com/news/3294412-intelsatplus-1_5-echostarminus-1_7-on-new-ratings-jefferies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294405\" data-ts=\"1504877976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LAND\" target=\"_blank\">LAND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294405-gladstone-land-down-nearly-5-after-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gladstone Land down nearly 5% after capital raise</a></h4><ul><li>The company sold 1M shares of common stock at $12.25 each. The underwriters have a greenshoe option for another 150K shares at that price.</li><li><a href='https://seekingalpha.com/symbol/LAND' title='Gladstone Land'>LAND</a><font color='red'> -5%</font>&nbsp;to $12.20</li><li>Source: <a href=\"https://seekingalpha.com/pr/16935521-b-gladstone-b-land-corporation-announces-pricing-common-stock-offering\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3294405\" data-linked=\"Gladstone Land down nearly 5% after capital raise\" data-tweet=\"$LAND - Gladstone Land down nearly 5% after capital raise https://seekingalpha.com/news/3294405-gladstone-land-down-nearly-5-after-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3294405-gladstone-land-down-nearly-5-after-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294398\" data-ts=\"1504876882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294398-nokiaminus-2_1-amid-index-removal-job-cuts-in-france\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia -2.1% amid index removal, job cuts in France</a></h4><ul>   <li>Nokia (NYSE:<a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a>) is <font color='red'>off 2.1%</font> premarket in U.S. trading, following word that Euronext is bouncing it from the CAC 40 index, to be replaced by STMicroelectronics (NYSE:<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a>).</li>    <li>The move is effective Sept. 18, part of Euronext's annual revision of French indices.</li>    <li>Nokia's being removed from the SBF 120 and will be excluded from the CAC Large 60 Index.</li>    <li><a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a> is <font color='green'>up 0.5%</font> premarket on the NYSE.</li>    <li>Nokia also says it will cut around 600 jobs in France, a little over 10% of its workforce in the country. The cuts will focus on administrative/support services rather than on R&amp;D.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294398\" data-linked=\"Nokia -2.1% amid index removal, job cuts in France\" data-tweet=\"$NOK $NOK $STM - Nokia -2.1% amid index removal, job cuts in France https://seekingalpha.com/news/3294398-nokiaminus-2_1-amid-index-removal-job-cuts-in-france?source=tweet\" data-url=\"https://seekingalpha.com/news/3294398-nokiaminus-2_1-amid-index-removal-job-cuts-in-france\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294397\" data-ts=\"1504876687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294397-kroger-falls-sharply-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kroger falls sharply after earnings</a></h4><ul> <li>Kroger (NYSE:<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a>) falls sharply after the company says it won't provide long-term guidance.</li> <li>The grocery store operator roughly matched estimates with its Q2 report on a 0.9% gain in identical same-store sales, but the lack of color on the anticipated impact of the two major U.S. hurricanes along with the lack of long-term guidance has investors skittish.</li> <li>Oppenheimer is in early with a downgrade on Kroger to Perform from Outperform.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294363-kroger-eps-line-beats-revenue\" target=\"_blank\">Kroger EPS in-line, beats on revenue</a> (Sept. 8)</li> <li>Shares of Kroger are <font color='red'>down 6.32%</font> premarket to $21.33.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294397\" data-linked=\"Kroger falls sharply after earnings\" data-tweet=\"$KR - Kroger falls sharply after earnings https://seekingalpha.com/news/3294397-kroger-falls-sharply-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3294397-kroger-falls-sharply-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294396\" data-ts=\"1504876558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294396-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology'>KURA</a> <font color='green'>+34%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/pr/16934957-kura-oncology-announces-positive-phase-2-study-tipifarnib-hras-mutant-head-neck-cancer\" target=\"_blank\">positive topline</a> results from a Phase 2 trial for its lead product candidate, tipifarnib, in patients with HRAS mutant relapsed or refractory squamous cell carcinomas of the head and neck (HNSCC).</li><li><a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a>&nbsp;<font color='green'>+5%</font>&nbsp;on rucaparib <a href=\"https://seekingalpha.com/news/3294365-clovis-rucaparib-successful-late-stage-ovarian-cancer-study-shares-ahead-5-percent-premarket\" target=\"_blank\">successful</a> in late-stage ovarian cancer study.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294396\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$KURA $CLVS - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3294396-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3294396-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294395\" data-ts=\"1504876524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294395-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a>&nbsp;<font color='red'>-24%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3294264-tintri-beats-0_02-misses-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>&nbsp;<font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3294368-sharp-drop-american-outdoor-brands-guidance-cut\" target=\"_blank\">Q1 earnings</a> and guidance cut.</li><li><a href='https://seekingalpha.com/symbol/EFX' title='Equifax Inc.'>EFX</a>&nbsp;<font color='red'>-13%</font>&nbsp;on reporting <a href=\"https://seekingalpha.com/news/3294351-consumer-finance-industry-braces-equifax-fallout\" target=\"_blank\">cyberattack</a>.</li><li><a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/HBM' title='Hudbay Minerals Inc Ordinary Sh'>HBM</a> <font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16935195-hudbay-announces-c-242-million-bought-deal-financing\" target=\"_blank\">announcing</a> C$242M bought deal financing.</li><li><a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3294246-finisar-eps-line-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3294363-kroger-eps-line-beats-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/PAY' title='VeriFone Systems, Inc.'>PAY</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3294254-verifone-systems-eps-line-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3294395\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$TNTR-OLD $AOBC $EFX - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3294395-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3294395-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294393\" data-ts=\"1504876302\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INCY\" target=\"_blank\">INCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294393-incyte-prices-stock-offering-shares-down-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Incyte prices stock offering, shares down 2% premarket</a></h4><ul><li>Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) <a href=\"https://seekingalpha.com/pr/16935431-incyte-announces-pricing-public-offering-4945-000-shares-common-stock\" target=\"_blank\">prices </a>its public offering of 4.945M shares of common stock at, apparently, at undisclosed price. Underwriters over-allotment is an additional 741,750 shares. Net proceeds will be used for general corporate purposes.</li><li>Shares are down&nbsp;<font color='red'>2%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3294393\" data-linked=\"Incyte prices stock offering, shares down 2% premarket\" data-tweet=\"$INCY - Incyte prices stock offering, shares down 2% premarket https://seekingalpha.com/news/3294393-incyte-prices-stock-offering-shares-down-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3294393-incyte-prices-stock-offering-shares-down-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294390\" data-ts=\"1504875734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294390-canada-adds-22k-jobs-in-august-loonie-slides\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canada adds 22K jobs in August; loonie slides</a></h4><ul><li><a href=\"https://www.statcan.gc.ca/daily-quotidien/170908/dq170908a-eng.htm?HPA=1\" target=\"_blank\">The number topped</a> expectations for 15K jobs added. The unemployment rate dipped to 6.2% - its lowest level since October 2008.</li><li>Underneath the headlines, the economy lost 88K full-time jobs in August, but gained 110K part-time positions.</li><li>The loonie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>) has shed a few pips since the print, now flat vs. the greenback at $0.8252 - its strongest level in more than three years.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWC' title='iShares MSCI Canada ETF'>EWC</a>, <a href='https://seekingalpha.com/symbol/CNDA' title='IQ Canada Small Cap ETF'>CNDA</a>, <a href='https://seekingalpha.com/symbol/EWCS' title='iShares MSCI Canada Small Cap Index ETF'>EWCS</a>, <a href='https://seekingalpha.com/symbol/QCAN' title='SPDR MSCI Canada Quality Mix ETF'>QCAN</a>, <a href='https://seekingalpha.com/symbol/FCAN' title='First Trust Canada AlphaDex ETF'>FCAN</a>, <a href='https://seekingalpha.com/symbol/HEWC' title='iShares Currency Hedged MSCI Canada ETF'>HEWC</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3294390\" data-linked=\"Canada adds 22K jobs in August; loonie slides\" data-tweet=\"$FXC $EWC $CNDA - Canada adds 22K jobs in August; loonie slides https://seekingalpha.com/news/3294390-canada-adds-22k-jobs-in-august-loonie-slides?source=tweet\" data-url=\"https://seekingalpha.com/news/3294390-canada-adds-22k-jobs-in-august-loonie-slides\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294376\" data-ts=\"1504873533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOBC\" target=\"_blank\">AOBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294376-weak-read-on-demand-sends-gun-stocks-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak read on demand sends gun stocks lower</a></h4><ul> <li>Analysts think the inventory issues at American Outdoor Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>) could continue into the next quarter as firearms demand remains soft compared to a year ago.</li> <li>Price target drops on American Outdoor are in from Cowen ($19 from $27), Wedbush ($16 from $20) and Jefferies ($17 from $20).</li> <li>AOBC is <font color='red'>down 18.77%</font> premarket, while Sturm Ruger (NYSE:<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company Inc.'>RGR</a>) is <font color='red'>down 3.46%</font>. Vista Outdoor (NYSE:<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a>) is <font color='red'>off 1.93%</font> and Sportsman's Warehouse (NASDAQ:<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a>) is <font color='red'>1.15% lower</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294376\" data-linked=\"Weak read on demand sends gun stocks lower\" data-tweet=\"$AOBC $AOBC $RGR - Weak read on demand sends gun stocks lower https://seekingalpha.com/news/3294376-weak-read-on-demand-sends-gun-stocks-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3294376-weak-read-on-demand-sends-gun-stocks-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294368\" data-ts=\"1504872244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOBC\" target=\"_blank\">AOBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294368-sharp-drop-for-american-outdoor-brands-after-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sharp drop for American Outdoor Brands after guidance cut</a></h4><ul> <li>American Outdoor Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>) slumps after missing <a href=\"https://seekingalpha.com/pr/16934962-american-outdoor-brands-corporation-reports-first-quarter-fiscal-2018-financial-results\" target=\"_blank\">FQ1</a> earnings estimates and lowering guidance.</li> <li>\"Our financial results for the first quarter reflected lower than anticipated shipments in our Firearms business, consistent with a softening in wholesaler and retailer orders,\" says CEO James Debney.</li> <li>Gross margin came in at 31.5% of sales vs. 33.5% expected.</li> <li>The company now sees FQ2 sales of $140M to $150M vs. $174M consensus and Q2 EPS of $0.07 to $0.12 vs. $0.30 consensus. The outlook for the full year is for sales of $700M to $740M vs. $772M consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294263-american-outdoor-brands-misses-0_09-misses-revenue\" target=\"_blank\">American Outdoor Brands misses by $0.09, misses on revenue</a> (Sept. 7)</li> <li>Shares of AOBC are <font color='red'>down 18%</font> in premarket action to $13.78.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3294368\" data-linked=\"Sharp drop for American Outdoor Brands after guidance cut\" data-tweet=\"$AOBC - Sharp drop for American Outdoor Brands after guidance cut https://seekingalpha.com/news/3294368-sharp-drop-for-american-outdoor-brands-after-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3294368-sharp-drop-for-american-outdoor-brands-after-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294367\" data-ts=\"1504872197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COF\" target=\"_blank\">COF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294367-capone-synchrony-downgraded-morgan-stanley\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CapOne, Synchrony downgraded at Morgan Stanley</a></h4><ul><li>It's a \"tale of two consumers,\" says analyst Betsy Graseck, with the average consumer in good shape, but subprime consumers facing high and rising financial pressures.</li><li>Banks, she says, are pulling back on subprime card loan growth as discretionary income isn't keeping up rising debt service burdens.</li><li>Graseck boosts her expectations for subprime charge-offs, and downgrades Capital One (NYSE:<a href='https://seekingalpha.com/symbol/COF' title='Capital One Financial Corporation'>COF</a>) and Synchrony Financial (NYSE:<a href='https://seekingalpha.com/symbol/SYF' title='Synchrony Financial'>SYF</a>) to Equalweight.</li><li>Source: Bloomberg's Felice Maranz</li><li>SYF&nbsp;<font color='red'>-1.9%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3294367\" data-linked=\"CapOne, Synchrony downgraded at Morgan Stanley\" data-tweet=\"$COF $COF $SYF - CapOne, Synchrony downgraded at Morgan Stanley https://seekingalpha.com/news/3294367-capone-synchrony-downgraded-morgan-stanley?source=tweet\" data-url=\"https://seekingalpha.com/news/3294367-capone-synchrony-downgraded-morgan-stanley\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3294365\" data-ts=\"1504872125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLVS\" target=\"_blank\">CLVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3294365-clovis-rucaparib-successful-in-late-stage-ovarian-cancer-study-shares-ahead-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clovis&#39; rucaparib successful in late-stage ovarian cancer study; shares ahead 5% premarket</a></h4><ul><li>Clovis Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a>) is up&nbsp;<font color='green'>5%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16935140-clovis-oncology-presents-comprehensive-dataset-successful-phase-3-ariel3-maintenance\" target=\"_blank\">announcement</a> of positive results from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT01968213?term=ariel3&amp;cond=ovarian+cancer&amp;rank=1\" target=\"_blank\">ARIEL3 </a>study evaluating rucaparib in women with platinum-sensitive advanced ovarian cancer.</li><li>The trial achieved it primary endpoint of demonstrating a statistically valid improvement in progression-free survival &#40;PFS&#41; by both investigator review and blinded independent central review in each of the three populations studied.</li><li>Median PFS by investigator review in BRCA-positive patients was 16.6 months versus 5.4 months for placebo. In homologous recombination deficiency &#40;HRD&#41; patients, the difference was 13.6 months vs. 5.4 months and in the intent-to-treat group, 10.8 months vs. 5.4 months. All were highly statistically significant.</li><li>Median PFS superiority by blinded independent central review was more pronounced: 26.8 mo. vs . 5.4 mo., 22.9 mo. vs. 5.5 mo. and 13.7 mo. vs. 5.4 mo., respectively.</li><li>The results are being presented today at ESMO in Madrid.</li><li>The results will support a supplemental New Drug Application in the U.S. for second-line or later maintenance treatment of ovarian cancer, to be filed by the end of October. The company plans to file a marketing application Europe after the European Commission approves the initial use (marketing application filed in Q4 2016).</li><li>The FDA OK'd rucaparib, branded as Rubraca, in December 2016 for the treatment of patients with BRCA-positive ovarian cancer who have received at least two prior lines of chemo.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274184-clovis-rubraca-improved-pfs-patients-advanced-platinum-sensitive-ovarian-cancer-late-stage\" target=\"_blank\">Clovis' Rubraca improved PFS in patients with advanced platinum-sensitive ovarian cancer in late-stage study; U.S. marketing application within four months; shares ahead 41% premarket</a> (June 19)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3231454-fda-oks-clovis-rucaparib-ovarian-cancer-shares-15-percent\" target=\"_blank\">FDA OKs Clovis' rucaparib for ovarian cancer; shares up 15%</a> (Dec. 19, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3294365\" data-linked=\"Clovis&#39; rucaparib successful in late-stage ovarian cancer study; shares ahead 5% premarket\" data-tweet=\"$CLVS - Clovis&#39; rucaparib successful in late-stage ovarian cancer study; shares ahead 5% premarket https://seekingalpha.com/news/3294365-clovis-rucaparib-successful-in-late-stage-ovarian-cancer-study-shares-ahead-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3294365-clovis-rucaparib-successful-in-late-stage-ovarian-cancer-study-shares-ahead-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":54,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}